Literature DB >> 28922305

Mayer-Rokitansky-Küster-Hauser Syndrome With Bilateral Ovarian Sertoli Cell Tumors: Review of the Literature and Report of a Rare Case.

Alexander L Juusela, Ilana Naghi, Suresh Thani1.   

Abstract

BACKGROUND: Patients with Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome are infertile secondary to hypoplasia or complete agenesis of the uterus, yet they remain at risk of primary neoplasms of the ovaries because embryologically the uterus and ovaries develop via separate mechanisms. CASE: A 72-year-old nulliparous woman with a history of primary amenorrhea underwent an exploratory laparotomy for a suspected uterine fibroid. In addition to the pelvic mass, the patient was found to have findings consistent with MRKH syndrome. Postoperative pathological examination demonstrated bilateral ovarian Sertoli cell tumors.
CONCLUSIONS: The case presented is unique in that 2 rare pathologies, bilateral Sertoli cell tumors of the ovary and MRKH syndrome, developed concomitantly in the same patient.

Entities:  

Mesh:

Year:  2018        PMID: 28922305     DOI: 10.1097/SPV.0000000000000483

Source DB:  PubMed          Journal:  Female Pelvic Med Reconstr Surg        ISSN: 2151-8378            Impact factor:   2.091


  3 in total

1.  Co-occurrence of Mayer-Rokitansky-Küster-Hauser syndrome and ovarian cancer: A case report and review of the literature.

Authors:  Roberta Villa; Jacopo Azzollini; Bernard Peissel; Siranoush Manoukian
Journal:  Gynecol Oncol Rep       Date:  2019-03-17

Review 2.  Diagnosis and Management of Ovarian Tumor in Mayer-Rokitansky-Küster-Hauser (MRKH) Syndrome.

Authors:  Yali Miao; Jirui Wen; Liwei Huang; Jiang Wu; Zhiwei Zhao
Journal:  Biomed Res Int       Date:  2018-03-12       Impact factor: 3.411

3.  Mayer-rokitansky-kuster-hauser syndrome with presacral schwannoma presenting as a pelvic mass: A literature review and case report

Authors:  Raziye Narin; Sefa Özyazıcı; Mehmet Ali Narin; Sevtap Seyfettinoglu; Elife Aşut
Journal:  Turk J Obstet Gynecol       Date:  2021-12-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.